|
|
|
|
|
|
|
|
|
|
"What is more promising about this study was the utility in all of the cancers studied (ovarian, cervical, breast, testicular, and lung), demonstrating that combining HDAC inhibitors with other therapies may be clinically useful in multiple types of malignancies."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.